SCHEMBL19923770

SCHEMBL19923770

CC(C)N1C(=O)N([Si](C(C)C)(C(C)C)C(C)C)C(c2ccccc2)(C(C)C)C1=O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.35
USP2 O75604 1/20 0.34
ALDH1A1 P00352 4/20 0.34
MARK3 P27448 1/20 0.34
ADAMTS5 Q9UNA0 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
REN P00797 1/20 0.31
APP P05067 1/20 0.31
BACE1 P56817 1/20 0.31
BACE2 Q9Y5Z0 1/20 0.31
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP9 P14780 1/20 0.31
CYP2D6 P10635 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923722 0.87 SMN1; SMN2 (0.36) SMN1; SMN2USP2ALDH1A1MARK3ADAMTS5
SCHEMBL19923479 0.84 USP2 (0.36) SMN1; SMN2USP2ALDH1A1MARK3ADAMTS5
SCHEMBL19923401 0.83 SMN1; SMN2 (0.33) SMN1; SMN2USP2ALDH1A1MARK3ADAMTS5
SCHEMBL19923510 0.70
SCHEMBL19923434 0.70 SMN1; SMN2 (0.35) SMN1; SMN2ALDH1A1MEN1KMT2AREN
SCHEMBL19923517 0.69 ALDH1A1 (0.37) SMN1; SMN2ALDH1A1MEN1KMT2AREN
SCHEMBL19923700 0.68 HTR1A (0.40) SMN1; SMN2ALDH1A1MEN1KMT2AREN
SCHEMBL19923446 0.67 SMN1; SMN2 (0.41) SMN1; SMN2USP2ALDH1A1MARK3ADAMTS5
SCHEMBL19923489 0.67 ELANE (0.42) SMN1; SMN2ALDH1A1
SCHEMBL19923632 0.67 USP2 (0.35) SMN1; SMN2USP2ALDH1A1MARK3ADAMTS5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN SMN1; SMN2 1697/4885USP2 962/4885ALDH1A1 2648/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM SMN1; SMN2 1924/4885USP2 975/4885ALDH1A1 2554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.